Does ICD indication affect quality of life and levels of distress?

Susanne S. Pedersen, Samuel F Sears, Matthew M Burg, Krista C Van Den Broek

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Resumé

The implantable cardioverter defibrillator (ICD) is the treatment of choice for life-threatening arrhythmias, with ICD indications having recently been extended to include primary prophylaxis. Despite the medical benefits of the ICD, there is an ongoing debate as to the impact of the ICD on patients' lives, particularly whether primary prophylaxis implantation may impact adversely on patient-centered outcomes such as quality of life (QoL) and distress. We examined the evidence for a role of ICD indication on these patient-centered outcomes. A literature search was conducted on PubMed and Web of Science from 2002 to present, focusing on indication for ICD therapy and patient-centered outcomes (i.e., anxiety, depression, disease-specific, or general QoL). We identified five studies (seven articles) concerning the impact of indication on patient-centered outcomes. Sample sizes varied from 91-426 patients across studies, five of seven articles used a prospective design, and follow-up ranged from 2-12 months. No study reported an effect for indication on patient-centered outcomes. There is no evidence to suggest that patients receiving an ICD for primary prophylaxis have subsequent poorer QoL and greater distress than patients receiving an ICD for secondary prophylaxis. This knowledge may help cardiologists in the clinical management of patients, in particular when discussing ICD implantation with patients.
OriginalsprogEngelsk
TidsskriftPacing and Clinical Electrophysiology
Vol/bind32
Udgave nummer2
Sider (fra-til)153-156
ISSN0147-8389
DOI
StatusUdgivet - 2009

Fingeraftryk

Implantable Defibrillators
Quality of Life
PubMed
Sample Size
Depression

Citer dette

@article{71bf3a8153b04551ac05fa6c1e61cf87,
title = "Does ICD indication affect quality of life and levels of distress?",
abstract = "The implantable cardioverter defibrillator (ICD) is the treatment of choice for life-threatening arrhythmias, with ICD indications having recently been extended to include primary prophylaxis. Despite the medical benefits of the ICD, there is an ongoing debate as to the impact of the ICD on patients' lives, particularly whether primary prophylaxis implantation may impact adversely on patient-centered outcomes such as quality of life (QoL) and distress. We examined the evidence for a role of ICD indication on these patient-centered outcomes. A literature search was conducted on PubMed and Web of Science from 2002 to present, focusing on indication for ICD therapy and patient-centered outcomes (i.e., anxiety, depression, disease-specific, or general QoL). We identified five studies (seven articles) concerning the impact of indication on patient-centered outcomes. Sample sizes varied from 91-426 patients across studies, five of seven articles used a prospective design, and follow-up ranged from 2-12 months. No study reported an effect for indication on patient-centered outcomes. There is no evidence to suggest that patients receiving an ICD for primary prophylaxis have subsequent poorer QoL and greater distress than patients receiving an ICD for secondary prophylaxis. This knowledge may help cardiologists in the clinical management of patients, in particular when discussing ICD implantation with patients.",
keywords = "Arrhythmias, Cardiac, Comorbidity, Defibrillators, Implantable, Humans, Incidence, Quality of Life, Risk Assessment, Risk Factors, Stress, Psychological",
author = "Pedersen, {Susanne S.} and Sears, {Samuel F} and Burg, {Matthew M} and {Van Den Broek}, {Krista C}",
year = "2009",
doi = "10.1111/j.1540-8159.2008.02196.x",
language = "English",
volume = "32",
pages = "153--156",
journal = "Pacing and Clinical Electrophysiology",
issn = "0147-8389",
publisher = "Wiley-Blackwell",
number = "2",

}

Does ICD indication affect quality of life and levels of distress? / Pedersen, Susanne S.; Sears, Samuel F; Burg, Matthew M; Van Den Broek, Krista C.

I: Pacing and Clinical Electrophysiology, Bind 32, Nr. 2, 2009, s. 153-156.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

TY - JOUR

T1 - Does ICD indication affect quality of life and levels of distress?

AU - Pedersen, Susanne S.

AU - Sears, Samuel F

AU - Burg, Matthew M

AU - Van Den Broek, Krista C

PY - 2009

Y1 - 2009

N2 - The implantable cardioverter defibrillator (ICD) is the treatment of choice for life-threatening arrhythmias, with ICD indications having recently been extended to include primary prophylaxis. Despite the medical benefits of the ICD, there is an ongoing debate as to the impact of the ICD on patients' lives, particularly whether primary prophylaxis implantation may impact adversely on patient-centered outcomes such as quality of life (QoL) and distress. We examined the evidence for a role of ICD indication on these patient-centered outcomes. A literature search was conducted on PubMed and Web of Science from 2002 to present, focusing on indication for ICD therapy and patient-centered outcomes (i.e., anxiety, depression, disease-specific, or general QoL). We identified five studies (seven articles) concerning the impact of indication on patient-centered outcomes. Sample sizes varied from 91-426 patients across studies, five of seven articles used a prospective design, and follow-up ranged from 2-12 months. No study reported an effect for indication on patient-centered outcomes. There is no evidence to suggest that patients receiving an ICD for primary prophylaxis have subsequent poorer QoL and greater distress than patients receiving an ICD for secondary prophylaxis. This knowledge may help cardiologists in the clinical management of patients, in particular when discussing ICD implantation with patients.

AB - The implantable cardioverter defibrillator (ICD) is the treatment of choice for life-threatening arrhythmias, with ICD indications having recently been extended to include primary prophylaxis. Despite the medical benefits of the ICD, there is an ongoing debate as to the impact of the ICD on patients' lives, particularly whether primary prophylaxis implantation may impact adversely on patient-centered outcomes such as quality of life (QoL) and distress. We examined the evidence for a role of ICD indication on these patient-centered outcomes. A literature search was conducted on PubMed and Web of Science from 2002 to present, focusing on indication for ICD therapy and patient-centered outcomes (i.e., anxiety, depression, disease-specific, or general QoL). We identified five studies (seven articles) concerning the impact of indication on patient-centered outcomes. Sample sizes varied from 91-426 patients across studies, five of seven articles used a prospective design, and follow-up ranged from 2-12 months. No study reported an effect for indication on patient-centered outcomes. There is no evidence to suggest that patients receiving an ICD for primary prophylaxis have subsequent poorer QoL and greater distress than patients receiving an ICD for secondary prophylaxis. This knowledge may help cardiologists in the clinical management of patients, in particular when discussing ICD implantation with patients.

KW - Arrhythmias, Cardiac

KW - Comorbidity

KW - Defibrillators, Implantable

KW - Humans

KW - Incidence

KW - Quality of Life

KW - Risk Assessment

KW - Risk Factors

KW - Stress, Psychological

U2 - 10.1111/j.1540-8159.2008.02196.x

DO - 10.1111/j.1540-8159.2008.02196.x

M3 - Journal article

C2 - 19170902

VL - 32

SP - 153

EP - 156

JO - Pacing and Clinical Electrophysiology

JF - Pacing and Clinical Electrophysiology

SN - 0147-8389

IS - 2

ER -